ITI Pharma and Healthcare Fund Regular vs Quant Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹217 Cr | ₹402 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹1000 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 17 Jun 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare TRI |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.39 |
Manager | Rohan Korde | Sanjeev Sharma |
ISIN Code | INF00XX01BL5 | INF966L01CG3 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Month | -7.34% | -7.62% |
6 Month | -6.6% | -17.69% |
1 Year | 9.8% | 1.74% |
3 Year | 17.76% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
6 Month | - | - |
1 Year | 0.25% | -11.39% |
3 Year | 21.16% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Year | 24.79% | 55.41% |
3 Year | 19.26% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Standard Deviation | 15.667% | - |
Sharp | 0.739% | - |
Beta | 0.959% | - |
Alpha | -1.413% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Name | Rohan Korde | Sanjeev Sharma |
Total AUM | ₹4626 Cr | ₹39731 Cr |
Fund Manage | 10 | 22 |
ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 1.8 | 5.19 |
Large Cap | 38.11 | 15.52 |
Mid Cap | 26.43 | 18.76 |
Small Cap | 33.66 | 60.53 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 1.8 | 5.19 |
Pharmaceuticals & Biotechnology | 77 | 64.82 |
Healthcare Services | 18.01 | 9.02 |
Chemicals & Petrochemicals | 0.96 | - |
Fertilizers & Agrochemicals | 1.03 | - |
Insurance | 1.2 | - |
Petroleum Products | - | 7.46 |
Telecom - Services | - | 7.82 |
Food Products | - | 5.69 |
Top Comparisons
SBI Nifty Next 50 Index Fund - Regular Plan - Growth
3Y Returns14.5%
UTI Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns14.55%
BANDHAN Core Equity Fund - Regular Plan - Growth
3Y Returns20.67%
Tata Large & Mid Cap Fund- Regular Plan - Growth Option
3Y Returns14.21%
Kotak Debt Hybrid - Growth
3Y Returns9.34%
SBI Conservative Hybrid Fund - Regular Plan - Growth
3Y Returns8.89%
BANDHAN Corporate Bond Fund - Regular Growth
3Y Returns5.78%
HSBC Corporate Bond Fund - Regular Growth
3Y Returns5.79%